These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35774551)

  • 21. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
    Fifi A; Raphael BP; Terreri B; Uddin S; Kaufman SS
    J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):666-671. PubMed ID: 37889619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B; Herfarth HH
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
    Kocoshis SA; Merritt RJ; Hill S; Protheroe S; Carter BA; Horslen S; Hu S; Kaufman SS; Mercer DF; Pakarinen MP; Venick RS; Wales PW; Grimm AA
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging treatment options for short bowel syndrome: potential role of teduglutide.
    Tee CT; Wallis K; Gabe SM
    Clin Exp Gastroenterol; 2011; 4():189-96. PubMed ID: 22016579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
    Chiba M; Masumoto K; Kaji T; Matsuura T; Morii M; Fagbemi A; Hill S; Pakarinen MP; Protheroe S; Urs A; Chen ST; Sakui S; Udagawa E; Wada M
    J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):339-346. PubMed ID: 37364133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.
    Jeppesen PB
    Therap Adv Gastroenterol; 2012 May; 5(3):159-71. PubMed ID: 22570676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging intestinal failure with Teduglutide - A case report.
    Schlager L; Stift A; Gartner J; Hütterer E; Harpain F
    Int J Surg Case Rep; 2021 Sep; 86():106270. PubMed ID: 34418803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
    Ukleja A; To C; Alvarez A; Lara LF
    JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
    Yazbeck R
    Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease.
    Siu RK; Karime C; Hashash JG; Kinnucan J; Picco MF; Farraye FA
    Crohns Colitis 360; 2024 Jan; 6(1):otae007. PubMed ID: 38352117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome.
    Burness CB; McCormack PL
    Drugs; 2013 Jun; 73(9):935-47. PubMed ID: 23729002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teduglutide for the treatment of short bowel syndrome.
    Ferrone M; Scolapio JS
    Ann Pharmacother; 2006 Jun; 40(6):1105-9. PubMed ID: 16705029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
    Iturrino J; Camilleri M; Acosta A; O'Neill J; Burton D; Edakkanambeth Varayil J; Carlson PJ; Zinsmeister AR; Hurt R
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1089-1095. PubMed ID: 26223941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
    de Dreuille B; Cazals-Hatem D; Ronot M; Theou-Anton N; Dermine S; Le Beyec-Le Bihan J; Billiauws L; Le Gall M; Bado A; Joly F
    Am J Clin Nutr; 2023 Jun; 117(6):1143-1151. PubMed ID: 37270288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.